64 results
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation
8-K
EX-4.1
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof during the course of the investigation or defense … , and of the Placement Agents set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made
8-K
EX-4.2
fn4t7x
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
yfiejh9nl2yhxmr898
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
s037wm uco7
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
6p29igz
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-1.1
tygvmbhn 5adn
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am